This Article Full Text Full Text (PDF) Submit a related Letter to the Editor Purchase Article View Shopping Cart Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Copyright Permission Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Corleto, V. D. Articles by Annibale, B. Search for Related Content PubMed PubMed Citation Articles by Corleto, V. D. Articles by Annibale, B.

Prevalence and Causes of Hypergastrinemia in Primary Hyperparathyroidism: A Prospective Study¹

Gastroenterology Unit 1 (A.M., C.G., S.C., G.D.F., B.A.), Internal Medicine IV (S.M., C.D., G.S.), Semeiotica Chirurgica IV (G.D.A.), and Department of Cellular Biotechnology and Haematology (V.D.C., R.S.), University La Sapienza, 00161 Rome; and Department of Pathology (C.B.), University of Parma, 43100 Parma, Italy

Address correspondence and requests for reprints to: Gianfranco Delle Fave, M.D., Cattedra di Gastroenterologia, Dipart.Di Medicina Clinica, Policlinico Umberto I, 00161 Rome, Italy. E-mail: dddhgi{at}tin.it

Gastrin levels have been reported to be often increased in patients with primary hyperparathyroidism (PHPT) considered to be caused by hypercalcemia. To determine the prevalence of increased basal gastrin and to investigate its causes, 52 consecutive patients with PHPT were studied prospectively, undergoing a clinical, biochemical, and gastric morphofunctional assessment before any parathyroid surgical procedure. This included evaluation of basal and secretin-stimulated gastrin, basal and pentagastrin-stimulated gastric acid secretion, upper gastrointestinal endoscopy, with histological evaluation for gastritis and Helicobacter pylori infection. Twenty of the 52 PHPT patients (38.5%) had increased fasting gastrin. Further investigation allowed us to clearly demonstrate the causes of hypergastrinemia in 16 of these 20 patients. In 7 of 20 (35%), hypergastrinemia was caused by gastric fundus atrophy; in 3 patients (15%), Zollinger-Ellison syndrome with Multiple Endocrine Neoplasia type I was diagnosed; whereas in another 20% of patients, mild hypergastrinemia was ascribed to Helicobacter pylori gastritis. Finally, in 2 patients, additional clinical history revealed an occasional use of the gastric antisecretory drug omeprazole a few days before the serum gastrin determination. This study shows that the hypercalcemic status per se is not sufficient to produce an increase in fasting gastrin levels. Furthermore, gastric fundus atrophy, and not gastrinoma, is the major cause of relevant (>160 pg/mL) hypergastrinemia.

This article has been cited by other articles:

				M Peracchi, C Gebbia, G Basilisco, M Quatrini, C Tarantino, C Vescarelli, S Massironi, and D Conte Plasma chromogranin A in patients with autoimmune chronic atrophic gastritis, enterochromaffin-like cell lesions and gastric carcinoids Eur. J. Endocrinol., March 1, 2005; 152(3): 443 - 448. [Abstract] [Full Text] [PDF]

				C. A. Carrasco, A. A. Gonzalez, C. A. Carvajal, C. Campusano, E. Oestreicher, E. Arteaga, N. Wohllk, and C. E. Fardella Novel Intronic Mutation of MEN1 Gene Causing Familial Isolated Primary Hyperparathyroidism J. Clin. Endocrinol. Metab., August 1, 2004; 89(8): 4124 - 4129. [Abstract] [Full Text] [PDF]